• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsHarrow
    Picture of Harrow logo

    HROW — Harrow News Story

    $28.150.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapFalling Star
    • Market Cap
      $1.06bn
    • Enterprise Value
      $1.26bn
    • Revenue
      $272.30m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • HROW Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    HROW Dividends
    All News

    U.S. STOCKS ON THE MOVE-Super Micro Computer, WEX, MarketAxess

    Picture of Harrow logoHarrow
    06/02/2025 18:44

    Recent news on Harrow

    See all news
    • Harrow, Inc. reports results for the quarter ended June 30 - Earnings Summary

      10/08/2026 22:00
    • Harrow Q2 revenue slightly beats estimates

      10/08/2026 21:19
    • Viatris raises annual profit forecast on branded drug strength

      06/08/2026 12:54
    • Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare

      10/06/2026 12:04
    • Harrow Q1 revenue misses analyst estimates

      11/05/2026 21:22

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.